Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Comparing zero-based and cash flow budgeting reveals how each method handles income allocation, expenses, and optimization opportunities.
28,655 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
A growing cohort of dentists is turning to cash-balance plans to fund retirement beyond 401(k) limits, giving practic...
A sharp pullback in the IGV ETF puts a spotlight on Oracle’s ability to generate free cash flow amid AI investments. ...
Robinhood's Layer-2 testnet on Arbitrum logs 4 million transactions in week one, signaling a rapid move toward on-cha...
On a day of mixed signals, Bank of America and peers moved as tariffs and earnings chatter swirled. This article brea...
Fan tokens are shifting from novelty to data assets, with clubs using on chain activity to measure sentiment, reward ...
SPYM and QQQ offer different paths to U.S. stock exposure. This guide explains when SPYM might fit a portfolio better...
Amsterdam moves to ban outdoor ads promoting meat, fossil fuels, and high-emission travel, part of a wider European p...
Akron is weighing a plan to remove minimum lot size rules to unlock hundreds of vacant parcels and accelerate infill ...
A bold forecast surrounds Shiba Inu: that it will never reclaim its all-time high. This article breaks down the logic...
A leading analyst has reiterated a $250 SpaceX target, arguing that SpaceX's physical AI capabilities could reshape r...
A new Ipsos poll reveals growing World Cup enthusiasm among U.S. fans while broad adoption lags. The findings hint at...